Ana Alfirevic

7.1k total citations · 2 hit papers
98 papers, 4.0k citations indexed

About

Ana Alfirevic is a scholar working on Pharmacology, Pharmacology and Immunology. According to data from OpenAlex, Ana Alfirevic has authored 98 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pharmacology, 20 papers in Pharmacology and 18 papers in Immunology. Recurrent topics in Ana Alfirevic's work include Drug-Induced Adverse Reactions (32 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Pharmaceutical studies and practices (9 papers). Ana Alfirevic is often cited by papers focused on Drug-Induced Adverse Reactions (32 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Pharmaceutical studies and practices (9 papers). Ana Alfirevic collaborates with scholars based in United Kingdom, United States and Sweden. Ana Alfirevic's co-authors include Munir Pirmohamed, Andrea Jorgensen, Andrew R. Jones, Faviel F. González-Galarza, Eduardo José Melo dos Santos, Derek Middleton, Louise Y.C. Takeshita, F. Javier Vilar, Dyfrig Hughes and Andréa Luciana Soares da Silva and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Ana Alfirevic

95 papers receiving 3.9k citations

Hit Papers

Allele frequency net 2015... 2014 2026 2018 2022 2014 2019 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Alfirevic United Kingdom 32 1.2k 1.1k 712 630 492 98 4.0k
John Farrell United States 30 1.2k 1.0× 487 0.4× 406 0.6× 287 0.5× 266 0.5× 102 2.8k
Christopher Banfield United States 30 426 0.4× 447 0.4× 425 0.6× 328 0.5× 515 1.0× 88 2.8k
Chonlaphat Sukasem Thailand 29 1.1k 0.9× 220 0.2× 781 1.1× 341 0.5× 277 0.6× 182 2.9k
Gilles Paintaud France 43 331 0.3× 1.7k 1.6× 260 0.4× 948 1.5× 965 2.0× 194 6.3k
John M. Kovarik Switzerland 44 504 0.4× 626 0.6× 285 0.4× 1.6k 2.6× 1.0k 2.0× 137 5.9k
Diane R. Mould United States 34 248 0.2× 1.2k 1.1× 184 0.3× 923 1.5× 640 1.3× 140 4.5k
Lei Shen China 34 446 0.4× 2.0k 1.8× 317 0.4× 1.1k 1.7× 663 1.3× 119 6.4k
Mario Regazzi Italy 36 430 0.4× 311 0.3× 223 0.3× 369 0.6× 410 0.8× 136 3.6k
Thomas Urban United States 31 205 0.2× 686 0.6× 682 1.0× 907 1.4× 1.0k 2.1× 65 5.9k
Dennis A. Hesselink Netherlands 43 248 0.2× 740 0.7× 888 1.2× 536 0.9× 1.1k 2.3× 262 6.9k

Countries citing papers authored by Ana Alfirevic

Since Specialization
Citations

This map shows the geographic impact of Ana Alfirevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Alfirevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Alfirevic more than expected).

Fields of papers citing papers by Ana Alfirevic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Alfirevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Alfirevic. The network helps show where Ana Alfirevic may publish in the future.

Co-authorship network of co-authors of Ana Alfirevic

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Alfirevic. A scholar is included among the top collaborators of Ana Alfirevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Alfirevic. Ana Alfirevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Alfirevic, Ana, et al.. (2023). Developing In Vitro Models to Define the Role of Direct Mitochondrial Toxicity in Frequently Reported Drug-Induced Rhabdomyolysis. Biomedicines. 11(5). 1485–1485. 6 indexed citations
4.
Gupta, Juhi, Angharad Care, Laura Goodfellow, et al.. (2022). Genome and transcriptome profiling of spontaneous preterm birth phenotypes. Scientific Reports. 12(1). 1003–1003. 13 indexed citations
5.
Care, Angharad, Juhi Gupta, Laura Goodfellow, et al.. (2021). Maternal selenium levels and whole genome screen in recurrent spontaneous preterm birth population: A nested case control study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 265. 203–211. 2 indexed citations
6.
Goodfellow, Laura, Angharad Care, Andrew Sharp, et al.. (2021). Vaginal bacterial load in the second trimester is associated with early preterm birth recurrence: a nested case–control study. BJOG An International Journal of Obstetrics & Gynaecology. 128(13). 2061–2072. 30 indexed citations
7.
Ogese, Monday O., Adam Lister, Rosalind E. Jenkins, et al.. (2020). Characterization of Clozapine-Responsive Human T Cells. The Journal of Immunology. 205(9). 2375–2390. 13 indexed citations
8.
Lacaze, Paul, Kathlyn J. Ronaldson, Eunice J. Zhang, et al.. (2020). Genetic associations with clozapine-induced myocarditis in patients with schizophrenia. Translational Psychiatry. 10(1). 37–37. 26 indexed citations
9.
Giebel, Clarissa, Jason C. McIntyre, Ana Alfirevic, et al.. (2020). The longitudinal NIHR ARC North West Coast Household Health Survey: exploring health inequalities in disadvantaged communities. BMC Public Health. 20(1). 1257–1257. 11 indexed citations
11.
Alfirevic, Ana, et al.. (2020). SPECIAL ECONOMIC ZONES: THE IMPACT AND IMPLICATIONS ON ECONOMIC ROWTH WITH REFERENCE TO THE CHINESE MODEL. SHILAP Revista de lepidopterología. 18(32). 85–106. 1 indexed citations
12.
Siddiqui, Moneeza K., Abirami Veluchamy, Cyrielle Maroteau, et al.. (2017). CKM Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With Myalgia. Circulation Cardiovascular Genetics. 10(4). 3 indexed citations
13.
Plumpton, Catrin, Ana Alfirevic, Munir Pirmohamed, & Dyfrig Hughes. (2017). Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout. Lara D. Veeken. 56(10). 1729–1739. 46 indexed citations
14.
Alfirevic, Ana, Jill Durocher, David Dickens, et al.. (2015). Misoprostol-Induced Fever and Genetic Polymorphisms in Drug Transporters SLCO1B1 and ABCC4 in Women of Latin American and European Ancestry. Pharmacogenomics. 16(9). 919–928. 13 indexed citations
15.
Vasieva, Olga, et al.. (2014). Pathway Analysis of Genetic Factors Associated with Spontaneous Preterm Birth and Pre-Labor Preterm Rupture of Membranes. PLoS ONE. 9(9). e108578–e108578. 58 indexed citations
16.
Bloch, Katarzyna, Graeme J. Sills, Munir Pirmohamed, & Ana Alfirevic. (2014). Pharmacogenetics of Antiepileptic Drug-Induced Hypersensitivity. Pharmacogenomics. 15(6). 857–868. 37 indexed citations
17.
Dickens, David, Siti R. Yusof, N. Joan Abbott, et al.. (2013). A Multi-System Approach Assessing the Interaction of Anticonvulsants with P-gp. PLoS ONE. 8(5). e64854–e64854. 26 indexed citations
18.
19.
Mirza, Nasir, Ana Alfirevic, Andrea Jorgensen, Anthony G Marson, & Munir Pirmohamed. (2011). Metabolic acidosis with topiramate and zonisamide. Pharmacogenetics and Genomics. 21(5). 297–302. 43 indexed citations
20.
Alfirevic, Ana, Tracy Mills, Pauline Harrington, et al.. (2006). Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster. Pharmacogenetics and Genomics. 16(4). 287–296. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026